Expression of CD163 in hereditary gingival fibromatosis: a possible association with TGF-β1

Abstract

Background

Although several studies have discussed some of the molecular and cellular changes associated with hereditary gingival fibromatosis (HGF), its pathogenesis is still largely unclear. This study was directed to detect and outline the degree of relationship between the immunophenotyped macrophages (M2) expressing CD163 and TGF-β1 in patients with gingival overgrowth due to HGF.

Methods

Biopsies from 20 patients suffering from HGF and 20 normal control subjects were harvested, histologically and immunohistochemically stained then, analyzed and statistically compared and correlated for CD163 immunoexpression and TGF-β1.

Results

All HGF specimens expressed TGF-β1 by most of the connective tissue fibroblasts, with statistically high significant mean of area % (2.61±0.41) compared to normal controls (0.11±0.06) (p=0.001). All control specimens revealed negligible CD163 immunostaining of the few inflammatory cells found with a mean area of % (0.69±0.12), while the specimens of HGF cases showed statistically significant higher CD163 expression (3.39±0.75) at (p=0.007). A statistically significant higher mean % of M2-cells expressing CD163 in relation to the total number of the inflammatory cells was revealed in HGF (34.46±2.04) compared to the control group (16.36±2.39) (p-value ≤ 0.05). Moderate correlation between CD163 and TGF-β1 was detected in HGF (r =0.451), (p-value<0.05).

Conclusions

CD163 and TGF-β1 were clearly expressed in HGF cases compared to healthy control patients, with significant correlation. In HGF, the increase in CD 163-positive cells was specific and not dependent on the chronic gingival inflammation.

This article is protected by copyright. All rights reserved.

http://ift.tt/2D2znqx